Honey v. Bayhealth Medical Center, Inc.

        IN THE SUPERIOR COURT OF THE STATE OF DELAWARE
                    IN AND FOR KENT COUNTY

JEAN F. HONEY,                  :
                                :                 C.A. No: K13C-05-018 RBY
                  Plaintiff,    :
                                :
      v.                        :
                                :
BAYHEALTH MEDICAL CENTER, INC., :
a Delaware corporation, and     :
ERIC M. HITCHCOCK, D.O.,        :
                                :
                  Defendants.   :


                            Submitted: July 17, 2015
                             Decided: July 28, 2015


           Upon Consideration of Defendants’ Motion in Limine to
       Preclude Plaintiff from Introducing Medical Expenses Exceeding
               Amounts Actually Paid or Payable by Medicare
                                  GRANTED

                                    ORDER

William D. Fletcher, Jr., Esquire, Schmittinger & Rodriguez, P.A., Dover, Delaware
for Plaintiff.

James E. Drnec, Esquire, and Melony R. Anderson, Esquire, Balick & Balick, LLC,
Wilmington, Delaware for Defendant Bayhealth Medical Center, Inc.

Bradley J. Goewert, Esquire, and Lorenza A. Wolhar, Esquire, Marshall Dennehey
Warner Coleman & Goggin, Wilmington, Delaware for Defendant Eric M. Hitchcock,
D.O.


Young, J.
Honey v. Bayhealth, et. al.
C.A. No.: 13C-05-018 RBY
July 28, 2015

                                        SUMMARY
       The Delaware Supreme Court in Stayton v. Delaware Health Corp.,1
recently determined limits of the collateral source rule regarding healthcare bill
amounts written-off by medical providers, where the injured party is covered by
Medicare. The Stayton Court held that an injured Plaintiff’s damages stemming
from the costs of medical treatment are limited to amounts actually paid by
Medicare, rather than the amounts billed to Medicare.
       During the Supreme Court’s consideration of that issue, Bayhealth Medical
Center, Inc. (“Defendant Bayhealth”) and Dr. Eric M. Hitchock (“Defendant Dr.
Hitchock,” and, together with Bayhealth “Defendants”) filed a motion in limine in
the case at bar, seeking to prevent Jean F. Honey (“Plaintiff”), a Medicare
Advantage enrollee, from presenting evidence of medical expenses above that
which her Medicare Advantage insurer, Bravo Health, Inc. (“Bravo Health”)
actually paid. Given the pending case before the Supreme Court, which concerned
the Medicare issue, the Court stayed consideration of Defendants’ motion.
       Although the Supreme Court’s ruling resolves the question regarding the
collateral source rule and Medicare write-offs, it does not specifically address
situations in which a plaintiff is enrolled in a Medicare Advantage plan, such as
the one administered by Bravo Health. This case requires determination as to
whether the Plaintiff in the case at bar was insured under traditional Medicare,
and, thus, is subject to Stayton’s limitation on the collateral source rule, or was



       1
           2015 WL 3654325, at *1 (Del. Jun. 12, 2015).

                                                2
Honey v. Bayhealth, et. al.
C.A. No.: 13C-05-018 RBY
July 28, 2015

instead covered by a private health insurer.
       For the reasons that follow, the Court finds that Bravo Health, and other
Medicare Advantage insurers are within the larger Medicare system. Thus,
Plaintiff was insured by Medicare, and the Court GRANTS Defendants’ motion,
consistent with the Supreme Court’s directive in Stayton.
                              FACTS AND PROCEDURES
       On March 1, 2012, Plaintiff underwent a laparoscopic cholecystectomy at
Bayhealth’s Milford Memorial Hospital, performed by Defendant Dr. Hitchcock.
Plaintiff alleges that the surgery resulted in a urinary bladder laceration, leading to
further complications from an undetected post-operative intra-abdominal
hemorrhage. Defendant Dr. Hitchock’s negligent conduct in performing the
surgery, is purported to be the cause of Plaintiff’s injuries. Plaintiff claims she
suffered from immense pain and suffering, as well as having endured injuries to
her gastrointestinal and urinary systems.
       On May 16, 2013, Plaintiff filed an action sounding in medical negligence
against Defendant Dr. Hitchcock and Defendant Bayhealth. Plaintiff’s Complaint
alleges $217,437.50 in damages stemming from the treatment of Plaintiff’s
injuries, and that she will incur greater medical expenses in the future. At the time
of Plaintiff’s surgery, she was enrolled in a Medical Advantage program
administered by Bravo Health. Bravo Health is alleged to have covered the cost of
these healthcare charges.
       On November 5, 2014, Defendants’ filed a motion in limine to exclude



                                            3
Honey v. Bayhealth, et. al.
C.A. No.: 13C-05-018 RBY
July 28, 2015

medical expenses exceeding the amount actually paid by Bravo Health.2 By Order
dated January 23, 2015, this Court stayed consideration of that motion pending the
Delaware Supreme Court’s decision in Stayton. The Supreme Court issued its
decision on June 12, 2015. By letter dated June 15, 2015, this Court invited the
parties to submit supplemental briefing concerning the previously stayed motion.
                                          DISCUSSION
       In Stayton, the Supreme Court was faced with the question of whether the
collateral source rule should be extended to situations in which a plaintiff’s medical
care is covered by Medicare. The Supreme Court answered this query in the negative.
The significance of this for the instant matter is that Plaintiff was enrolled in a
Medicare Advantage program, also know as “Part C,” which was administered by
Bravo Health. The added complexity here, however, is that there exists some
controversy as to whether Medicare Advantage is part of the traditional Medicare
system, or, is instead, more like a private health insurer.3 During the pendency of the
stay, the Court requested that the parties fully brief this issue.4 Having both the
Supreme Court’s decision, and the parties’ respective positions concerning the nature
of Medicare Advantage, the Court may now proceed with disposition of Defendants’
motion.


       2
        The motion was filed by Defendant Dr. Hitchcock and was joined by Defendant
Bayhealth on November 19, 2014.
       3
        See e.g., D. Gary Reed Esq., Medicare Advantage Misconceptions Abound , 27 No.1
Health Law 1 (2014).
       4
           See Court’s Letter, dated January 5, 2015.

                                                  4
Honey v. Bayhealth, et. al.
C.A. No.: 13C-05-018 RBY
July 28, 2015

       By Delaware jurisprudence, the collateral source rule provides that tortfeasors
are forbidden the windfall arising from a third-party covering the expense of the
injured party’s potential damages.5 Within the context of medical treatment, in some
circumstances, the collateral source rule has prevented amounts written-off by
medical providers from reducing plaintiffs’ awards.6 That is, plaintiffs have been
permitted, in those circumstances, to recover the full amount charged for medical
care, rather than the amount actually paid. That philosophy has been applied to
situations where a plaintiff pays for the medical services himself, and to situations
where a plaintiff is insured by a private entity, covering the cost of medical care.7
       However, with respect to plaintiffs insured by Medicare, the Stayton decision
has stated otherwise:
    We conclude that the collateral source rule does not apply to amounts
    required to be written off by Medicare. Where a healthcare provider has
    treated a plaintiff covered by Medicare, the amount paid in medical services
    is the amount recoverable by the plaintiff as medical expense damages.8
The holding is clear. Any amounts not actually paid by Medicare are not recoverable
as damages by the Plaintiff. Had the Plaintiff in the case at bar been covered by
traditional Medicare, the inquiry would end there. Instead, Plaintiff was enrolled in


       5
           Stayton, 2015 WL 3654325 at *4.
       6
           Id., at *6.
       7
        Onusko v. Kerr, 880 A.2d 1022 (Del. 2005)(as applied to plaintiff covering his own
medical expenses); Mitchell v. Haldar, 883 A.2d 32 (Del. 2006)(as applied to medical expenses
covered by private health insurer).
       8
           Stayton, 2015 WL 3654325 at *1.

                                              5
Honey v. Bayhealth, et. al.
C.A. No.: 13C-05-018 RBY
July 28, 2015

a Medicare Advantage plan administered by Bravo Health. The Court must, therefore,
determine whether Medicare Advantage is considered part of the traditional Medicare
program, or treated as a private carrier. If part of the Medicare program, then the
collateral source rule does not apply.
       Some jurisdictions have viewed Medicare beneficiaries who choose to enroll
in a Medicare Advantage program as “opting out” of traditional Medicare.9 Such a
depiction speaks to Medicare Advantage as something removed from traditional
Medicare. Others, by contrast, view Part C as well within the Medicare scheme.10 As

       9
          See e.g., Sunshine Haven Nursing Operations, LLC v. United States HHS, 742 F.3d
1239, 1258 n. 2 (10th Cir. 2014) (“Part C allows eligible participants to opt out of traditional
Medicare and instead obtain various benefits through [private insurers called Medicare
Advantage organizations]”; Parra v. Pacificare of Ariz., Inc., 715 F.3d 1146, 1152-1153 (9th Cir.
2013) (“Part C allows eligible participants to opt out of traditional Medicare and instead obtain
various benefits through MAOs”); United States ex rel. Wilkins v. United Health Group, Inc.,
659 F.3d 295, 300 n. 3 (3d Cir. 2011) (“opt out of traditional fee-for-service coverage under
Medicare Parts A and B and enroll in privately-run managed care plans”); First Med. Health
Plan, Inc. v. Vega-Ramos, 479 F.3d 46, 47 (1st Cir. 2007) (“opt out of traditional fee-for-service
coverage”); Born v. Sebelius, 968 F. Supp. 2d 1109, 1113 (D. Colo. 2013) (“allows eligible
participants to opt out of the traditional Part A fee-for-service system and instead obtain various
benefits through Medical Advantage Organizations”); Mann v. Reeder, 2010 WL 5341934, *3
(W.D. Ky. Dec. 21, 2010) (“opt out of traditional coverage under Medicare Parts A and B”);
Bolden v. Healthspring of Ala., Inc., 2007 WL 4403588, *7 (S.D. Ala. Oct. 2, 2007) (“to opt out
of the traditional fee-for-service coverage under Parts A and B”); Estate of Ethridge v. Recovery
Mgmt. Sys., 326 P.3d 297, 301 (Ariz. Ct. App. 2014) (“to opt out of traditional Medicare and
instead obtain both Part A and Part B coverage through private companies approved by CMS”).
       10
          See e.g., U.S. v. Lopez-Diaz, 940 F. Supp. 2d 39, 47 (D.P.R. 2013) (“Defendant JLD
argues that he only submitted bills ‘to privately owned insurance companies, which pay from
private funds and not from Medicare funds. The government's evidence of over 1,700 ‘CMS
1500 claims forms,’ however, show that defendant JLD submitted billing claims to Medicare
Advantage Plans. A Medicare Advantage Plan (“MAP”) is a type of Medicare health plan offered
by a private company that contracts with Medicare to provide beneficiaries with Medicare
benefits. Beneficiaries who participate in these plans still benefit from Medicare via Part C of the

                                                 6
Honey v. Bayhealth, et. al.
C.A. No.: 13C-05-018 RBY
July 28, 2015

to the former approach, those few legal scholars who have considered the subject,
almost unanimously, reject it, claiming a widespread judicial misunderstanding of the
operation of the Medicare system.11 The parties, in their respective briefing of the
issue, focus upon both the composition and operation of Medicare Advantage
programs, highlighting such features as the payment of benefits, relationships with
medical providers, and recovery rights against tortfeasors who injure enrollees.
       It is helpful to map out the structure of the Medicare system, noting that the
Medicare Act has been described as “one of the most completely impenetrable texts
within human experience.”12 Most relevant to our inquiry, Medicare includes Part A
and Part B, the “traditional” Medicare, or “pay-per-service” Medicare, which is
government-administered. It includes also Part C, known as the Medicare Advantage
option, in which private organizations (“Medicare Advantage Organization,” or,




Medicare program.”) (emphasis added); Pagarigan v. Superior Court, 102 Cal. App. 4th 1121,
1133 (Cal. App. 2d Dist. 2002) (“Here, however, the ‘dealings' are not between an insurer and its
policyholder, but rather, between Medicare (the federal government) and Medicare beneficiaries
through the intermediary of Medicare health care service plans contracted with the federal
government to provide Medicare benefits”).
       11
         See e.g., Reed, supra; Jennifer Jordan, Is Medicare Advantage Entitled to Bring a
Private Cause of Action Under the Medicare Secondary Payer Act?, 41 Wm. Mitchell L. Rev.
1408 (2015); Eileen Kuo, Medicare Advantage: Medicare or “Private” Insurance?
Developments in Medicare Secondary Payer Law, 2013 Health L. Handbook § 12:5; But see
Elizabeth C. Borer, Modernizing Medicare: Protecting American’s Most Vulnerable Patients
From Predatory Health Care Marketing Through Accessible Legal Remedies, 92 Minn. L. Rev.
1165 (2008) (viewing Medicare Advantage option as part of growing effort to privatize the
Medicare system).
       12
            Parra, 715 F.3d at 1149.

                                                7
Honey v. Bayhealth, et. al.
C.A. No.: 13C-05-018 RBY
July 28, 2015

“MAO”) administer benefits to enrollees.13 Part C, added to the Medicare system after
the Act’s initial passage, was intended to “harness the power of private sector
competition to stimulate experimentation and innovation that would ultimately create
a more efficient and less expensive Medicare system.”14 Congress sought to achieve
this goal, by implementing a program, wherein the government would pay private
health insurers a flat rate per enrollee to administer and provide the same basic
benefits received under traditional Medicare.15 Pursuant to this scheme, the MAO
pays providers directly for the care received by Part C enrollees. To the extent that
this care exceeds the flat rate received from the government, the MAO assumes the
risk and cost.16 In the event the care costs less than the flat rate received, the MAO
is permitted to keep the difference as profit.17
       The statutory scheme further reflects a closely regulated MAO operation. To
be approved to be an MAO, the private insurer must enter a bidding process, meeting
certain threshold requirements.18 MAOs must be licensed in each State in which they
operate.19 MAOs must offer an “explanation of coverage” annually, approved by the

       13
         In re Avandia Mtking., Sales Practices & Prods. Liab. Litig., 685 F.3d 353, 357 (3d
Cir. 2012), cert. denied, 133 S.Ct. 1800 (2013).
       14
            Id.,at 363.
       15
            Jordan, supra at 1412-13; 42 U.S.C § 1395W-23 (2015); 42 U.S.C § 1395W-22 (2015).
       16
            Jordan, supra at 1413.
       17
            Id.
       18
            Id.
       19
            Jordan, supra at 1414; 42 U.S.C. § 1395W-25(a)(1) (1997) .

                                                 8
Honey v. Bayhealth, et. al.
C.A. No.: 13C-05-018 RBY
July 28, 2015

Centers for Medicare & Medicaid (“CMS”) to enrollees.20 In providing the basic
benefits offered to traditional Medicare enrollees, MAOs are constrained by, and must
abide by, national coverage determinations provided by CMS.21 In addition, all
coverage disputes between enrollees and MAOs must go through the traditional
Medicare appeals process.22 The decisions coming out of the Medicare appeals
process are, moreover, binding upon the MAO.23 There is some discretion given
MAOs, however, with respect to the provision of services, to wit, the ability to
control how enrollees get said services, as well as the ability to establish networks of
accepted healthcare providers.24
       In establishing their respective positions, the parties cite to and employ several
of the above referenced considerations, in their supplemental briefing. Plaintiff
focuses primarily upon the discretionary aspects of an MAO’s operation, including
the ability to determine to some degree the provision of, and payment for services, as
well as the independent relationships established between MAOs and healthcare
providers. Plaintiff also notes the fact that MAOs, such as Bravo Health, are privately
established entities, having the ability to be bought and sold by private actors. The

       20
            Jordan, supra at 1414; 42 C.F.R. § 422.111 (2015).
       21
            42 C.F.R § 422.101(b).
       22
         Jordan, supra at 1413; 42 C.F.R § 405.904(a); Weinberger v. Salfi, 422 U.S. 749, 760-
761 (1975).
       23
         Reed, supra at *7 (citing 42 C.F.R. § 422.576 (organizational determination); 42 C.F.R.
§ 422.596 (reconsideration); 42 C.F.R. § 405.1048 (ALJ decision); 42 C.F.R. § 405.1130
(Medicare Appeals Counsel decision)).
       24
            Jordan, supra at 1414.

                                                 9
Honey v. Bayhealth, et. al.
C.A. No.: 13C-05-018 RBY
July 28, 2015

Court understands this point to mean that Bravo Health is not a mere appendage of
the Federal government, having the ability to make decisions about its existence and
governance internally, outside of federal oversight. Defendants, meanwhile, direct the
Court’s attention to the federal constraints and federal watchful eye, under which
MAOs operate, pointing to the intensive regulatory framework surrounding Part C.
       Although there are both discretionary and regulated aspects to an MAO’s
operation, the latter certainly outweigh the former. This is particularly evident in the
framework within which the private health insurers administering Part C coverage
exist. The federal government established the Medicare system and, subsequently,
made the decision to allow private insurer’s into it. It is the federal government which
sets the fixed rate at which MAOs will be remunerated. Likewise, the federal
government establishes the basic services that each Part C private insurer participant
must provide. These private health insurers are, further, constrained in their ability
to deny coverage, limited to the decisions of federally anointed adjudicators. The
discretion permitted these private insurers is within this federally created framework
– not outside or even alongside it.
       That the insurer is allowed to establish relationships with medical providers,
or to make payments on behalf of Medicare enrollees, does not create the discretion
pointing to an independent, private insurance plan. Many of these private insurers
offer insurance policies that are outside of the Medicare scheme.25 The main

       25
           For example, Bravo Health, the insurer in the case at bar, is now owned by Humana,
Inc., a private health insurer that provides both Medicare Advantage, as well as private plans for
individuals and businesses. See Company Profile and Get to Know Humana, HUMANA.COM,
https://www.humana.com/about/company-profile/(last visited Jul. 23, 2015).

                                                10
Honey v. Bayhealth, et. al.
C.A. No.: 13C-05-018 RBY
July 28, 2015

distinction is that in those private plans, the contract to provide insurance coverage
is between the insured and the insurer. Under Part C, the contract is between the
federal government and the insurer.26 Therefore, the defining factor of a truly private
insurance plan, one between insured and a insurer, is lacking.27 Of great significance
is that these contracts define the rights of insurers vis-à-vis their insureds. Among the
things contained in such contracts are provision of services and when such services
will be denied. Such basic determinations are out of the administrator’s hands in Part
C coverage – being decided instead by the other party to the contract – the federal
government.28 Hence, this is a federal contractor providing federal benefits,




       26
         Kuo, supra at § 12:5 (“MAOs provide the same benefits as would be provided under
Medicare Parts A and B and provides them pursuant to their contracts with CMS”); Reed, supra
at *3(“Part C contractors administer Medicare benefits under their contract with the federal
government and under federal law”)(emphasis in original).
       27
          Id. (“MAOs do not issue a Medicare ‘insurance policy’ but, rather, send out a document
describing the Medicare benefits that enrollees receive. They do not pay benefits pursuant to a
‘policy’ but rather under a statutory framework”); Reed, supra at *6-*7 (“[t]here is no such thing
as a [M]edicare Advantage policy. To elect a Medicare Advantage Plan, Medicare beneficiaries
do not complete an insurance application. To leave a Medicare Advantage plan, the Medicare
Advantage enrollee does not terminate or cancel an insurance policy...If a Medicare Advantage
enrollee does not receive benefits...they may not sue for breach of contract or for bad faith refusal
to pay benefits under an insurance policy”).
       28
          Jordan, supra at 1412-13 (MAOs must provide the same basic benefits as traditional
Medicare); Kuo, supra at § 12:5 (“MAOs must provide their enrollees copies of their Evidence
of Coverage describing, among other items, the benefits provided under Original Medicare as
well as any supplemental benefits offered by the MAO and the grievance and appeals procedures.
Any changes to the Evidence of Coverage must be approved by CMS”)(emphasis added); Reed,
supra at *7 ([benefit eligibility pursuant to Medicare appeals process] determination is binding
on the Medicare Advantage organization”).

                                                 11
Honey v. Bayhealth, et. al.
C.A. No.: 13C-05-018 RBY
July 28, 2015

established by the federal government, to federal constituents.29 Consistent with the
rationale of Stayton, the Court finds that the determination of Medicare Advantage
as within the broader Medicare system, rather than as a private insurance plan, is
called for.
       With these recovery rights in mind, it is helpful to review the rights attributed
to MAOs and from whence they come. Recent decisions, beginning with the Third
Circuit Court of Appeal’s opinion in In re Avandia Mtkg., have held that as regards
recovery of medical expenses by Part C insurers, stemming from torts, the recovery
rights arise out of the Medicare Act.30 That is, MAOs have their recovery rights
determined statutorily, just as traditional Medicare.31 Specifically, courts have found
that 42 U.S.C. § 1395y(b)(3)(A) provides a private right of action for MAOs to
recover medical expenses paid on behalf of enrollees.32 This finding of a statutory
right of recovery was made in juxtaposition to the argument that the right of recovery
is determined contractually in a MAO’s policy.33 As has been noted previously,

       29
          Reed, supra at *7-*8 (explaining that private insurers participating in Part C are federal
contractors, just like the many other contractors who perform delegated tasks by CMS in
traditional Medicare).
       30
        685 F.3d 353 (3d Cir. 2012); Collins v. Wellcare Health Plans, Inc., 2014 WL
7239426, at *1 (E.D. La. Dec. 16, 2014); Humana Med. Plan, Inc. v. Western Heritage Ins. Co.,
2015 WL 1191208, at *1 (S.D. Fla. Mar. 16, 2015).
       31
            Avandia, 685 F.3d 353.
       32
       Avandia, 685 F.3d 353; Collins, 2014 WL 7239426 at *1; Humana Med. Plan, Inc.,
2015 WL 1191208 at *1.
       33
         Avandia, 685 F.3d at 361 (describing the opponent’s argument “[i]nstead, such [MAO
recovery] rights can be secured by the MAO’s contract with an individual insured; that is, the
insurance policy”); see also Kuo supra § 12:5 (“By the same token, MAOs do not exercise the

                                                12
Honey v. Bayhealth, et. al.
C.A. No.: 13C-05-018 RBY
July 28, 2015

“[t]here is no such thing as a [M]edicare Advantage insurance policy.”34 Medicare
Advantage is, instead, a federal program.
       The significance of these decisions, announcing a private right of recovery by
Part C private insurers under the Medicare Act, is that they further support the
contention that Medicare Advantage is more akin to traditional Medicare, than a
private health insurance plan. Moreover, Stayton focused upon the difference between
the recovery rights of Medicare and private insurers. If an MAO’s right is defined
statutorily by the Medicare Act, than the same concern of Medicare’s not having a
subrogation right to written-off portions of the healthcare bill applies to an MAO. The
imbalance surrounding the potential windfall to Plaintiff, if the collateral source rule
were extended to MAOs would, under Stayton, still exist: “[i]f the collateral source
rule was employed to allow a plaintiff [covered by Medicare] to recover the full cost
of medical treatment she received for free...the rule would perversely provide for a
windfall for plaintiff, rather than fairly allocate an award of expenses to the party that
actually incurred them.”35 Here, Plaintiff, like the Stayton Plaintiff, paid for nothing.
       The reasoning of the Avandia line of cases is further consistent with the
Supreme Court’s ruling in Stayton, given the similar policy considerations underlying
these two sets of decisions. In rejecting the extension of the collateral source rule to
written-off portions of medical care that was paid for by Medicare, the Supreme Court


power to include ‘subrogation rights’ in their policies– rather, MAOs’ rights as secondary payers
are statutory”)(emphasis added).
       34
            Reed, supra at *6.
       35
            Stayton, 2015 WL 3654325 at *12 (Strine, C.J., concurring).

                                                13
Honey v. Bayhealth, et. al.
C.A. No.: 13C-05-018 RBY
July 28, 2015

noted that, rather than benefitting the injured party, discounted healthcare charges are
a boon to “federal taxpayers.”36 Such is not the purpose of the collateral source rule,
nor was it intended to operate this way.37 Similarly, the Avandia Court, in finding that
an MAO has a private right of action to recover payments made on behalf of an
enrollee for medical care, deemed its ruling in line with the Congressional intent
behind creating the Medicare Advantage option, which was to save costs:
“[a]ccordingly, when MAOs spend less on providing coverage for their enrollees, as
they will if they recover efficiently from primary payers, the Medicare Trust Fund
does achieve cost savings.”38 Again, we see that the financial benefit surrounding
Medicare recovery rights goes to the taxpayer – not the injured party. Therefore, an
MAO is squarely within the traditional Medicare system, advocating against an
extension of the collateral source rule to Part C enrollees.
       The Medicare Advantage is part of the larger Medicare system, rather than an
independent, private insurance plan. Therefore, as a component of Medicare,
Plaintiff’s damages stemming from medical expenses are limited to amounts actually
paid for by his MAO, here Bravo Health.




       36
            Id., at *9.
       37
          Id., at *9 (“based on quasi-punitive nature of tort law liability” collateral source rule is
intended to benefit the Plaintiff, at the expense of Defendant/Tortfeasor)(internal quotations
omitted).
       38
            685 F.3d at 365.

                                                  14
Honey v. Bayhealth, et. al.
C.A. No.: 13C-05-018 RBY
July 28, 2015

                               CONCLUSION
       For the foregoing reasons, Defendants’ motion in limine is GRANTED.
       IT IS SO ORDERED.

                                        /s/ Robert B. Young
                                                   J.

RBY/lmc
oc: Prothonotary
cc: Counsel
     Opinion Distribution




                                      15